MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kukhanova, M.
Right arrow Articles by Cheng, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kukhanova, M.
Right arrow Articles by Cheng, Y.-C.

Vol. 53, Issue 5, 801-807, May 1998

Interaction of beta -L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with Human Immunodeficiency Virus-1 Reverse Transcriptase and Human DNA Polymerases: Implications for Human Immunodeficiency Virus Drug Design

Marina Kukhanova, Xiuyan Li, Shu-Hui Chen, Ivan King, Terrence Doyle, William Prusoff, and Yung-Chi Cheng

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510 (M.K., W.P., Y.-C. C.), Vion Pharmaceuticals, Inc., New Haven, Connecticut 06511 (X.L., S.-H. C., I.K., T.D.)

The work reported in this article has evaluated the relative molecular activity of the 5'-triphosphate of a novel beta -L-nucleoside with an unsaturated ribose residue, beta -L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (beta -L-Fd4CTP), with that of beta -L-2',3'-dideoxy-5-fluorocytidine (beta -L-FddCTP) and 2',3'-dideoxycytidine (ddCTP), on DNA strand elongation by human immunodeficiency virus-1 reverse transcriptase (HIV RT) and human DNA polymerases alpha  (pol alpha ), beta  (pol beta ), gamma  (pol gamma ), and epsilon  (pol epsilon ). The concentrations of beta -L-Fd4CTP that inhibited the yield of products by 50% were 0.20 µM, 1.8 µM, and 4.0 µM for HIV RT, pol gamma , and pol beta , respectively. The beta -L-Fd4CTP at a concentration as high as 40 µM had no inhibitory effect on pol epsilon , but could inhibit pol alpha  by 10-20% at 20 µM. The Km and relative Vmax values of beta -L-Fd4CTP, beta -L-FddCTP, and ddCTP for incorporation into the standing start point of 5'-[32P]-oligonucleotide primer annealed with M13mp19 phage DNA by HIV RT and human DNA polymerases were evaluated. The efficiency of incorporation (Vmax/Km) of beta -L-Fd4CTP by HIV RT was about 4-fold and 12-fold higher than that of ddCTP and beta -L-FddCTP, respectively. In contrast, the Vmax/Km ratio of beta -L-Fd4CTP for pol gamma  was 7-fold lower than that of ddCTP, but 4-fold higher than that of beta -L-FddCTP. Pol alpha  could use beta -L-Fd4CTP as a substrate, but only at a high concentration (>20 µM). Incorporation of beta -L-Fd4CTP by pol epsilon  could not be detected. A hypothesis about the preferable recognition of the 2',3'-dideoxy-2',3'-didehydro- structure of beta -L-Fd4CTP to that of the 2',3'-dideoxy-structure of beta -L-FddCTP by HIV RT is discussed.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
M. S. Janes, B. J. Hanson, D. M. Hill, G. M. Buller, J. Y. Agnew, S. W. Sherwood, W. G. Cox, K. Yamagata, and R. A. Capaldi
Rapid Analysis of Mitochondrial DNA Depletion by Fluorescence In Situ Hybridization and Immunocytochemistry: Potential Strategies for HIV Therapeutic Monitoring
J. Histochem. Cytochem., August 1, 2004; 52(8): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. V. Sosunov, F. Santamaria, L. S. Victorova, G. Gosselin, B. Rayner, and A. A. Krayevsky
Stereochemical control of DNA biosynthesis
Nucleic Acids Res., March 1, 2000; 28(5): 1170 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. Le Guerhier, C. Pichoud, S. Guerret, M. Chevallier, C. Jamard, O. Hantz, X.-Y. Li, S.-H. Chen, I. King, C. Trépo, et al.
Characterization of the Antiviral Effect of 2',3'-Dideoxy-2', 3'-Didehydro-beta -L-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model
Antimicrob. Agents Chemother., January 1, 2000; 44(1): 111 - 122.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics